The study of lymphocyte signal transduction has changed greatly over the past 25 years. In the 1980s, the main approach was protein biochemical analysis of lymphoid cell lines or of cultured human primary lymphocytes. Genetic approaches in these systems were limited primarily to overexpression of constitutively active or dominant negative signaling proteins, usually in the presence of endogenous wild-type protein. With the advent of gene targeting technology in the 1990s, it became possible to study primary mouse lymphocytes missing individual signaling molecules (gene 'knockouts') and thereby to directly examine protein function without overexpression. Knockout mice also facilitated access to a broad range of lymphocyte subpopulations at distinct stages of differentiation; for example, in the T cell lineage it became possible to analyze signaling in developing thymocyte subsets, in naive CD4 + and CD8 + TCRαβ + and TCRγδ + T cells, and in differentiated effector subsets including T helper type 1 (T H 1) and T H 2 CD4 + T cells and CD8 + cytotoxic T cells. The physiological role of signaling molecules could also be investigated in the context of processes involving the whole body (for example, during an immune response or in autoimmunity).
One obvious limitation of straightforward gene knockouts is that if a molecule is essential for antigen receptor signaling, deletion of the gene often results in a developmental block because of the requirement for antigen receptor or pre-antigen receptor signals as cells pass through differentiation checkpoints. For example, inactivation of the ZAP70 tyrosine kinase or of the LAT and SLP76 adaptor proteins results in a strong block in thymic development and an absence of mature T cells [1] [2] [3] [4] [5] . Thus, it is not possible to study the role of these molecules in T cell biology using standard gene knockout technology. Furthermore, even if a mutation allows development of mature lymphocytes, it is possible that phenotypes observed in these cells are due to changes occurring during development in the thymus or bone marrow and may not accurately reflect the acute requirement for a given signaling molecule in a mature lymphocyte. Finally, in some cases where genes are important outside the lymphoid system, germline gene deletion results in embryonic lethality and, again, no analysis is possible in mature lymphocytes.
These problems can be addressed with conditional knockouts, using the Cre-loxP system to limit deletion of the target gene to specific cell lineages (for example, lymphoid cells) or stages of development (for example, starting during the CD4 + CD8 + stage of thymocyte development) 6 . For example, germline deletion of the gene encoding the Rac1 GTPase causes early embryonic lethality, but this can be circumvented using a conditional loxP-flanked allele and lymphoid-restricted expression of the Cre recombinase [7] [8] [9] . Although most use of the Cre-loxP system in lymphocytes has taken advantage of lineage-restricted or inducible transgenes expressing Cre, more recently, it has become possible to deliver Cre to mature lymphocytes in a variety of ways, including a cell-permeable Cre or by adenoviral gene transfer [10] [11] [12] .
However, even with careful spatial and temporal control of gene deletion, the phenotype of gene knockouts can give incomplete or paradoxical results. In some cases, a protein containing several different domains may exert multiple biochemical functions on a single signaling pathway or may serve as a cross-talk point linking several signaling pathways.
Complete deletion of such a protein would preclude dissection of its distinct functions. Even proteins with only one biochemical function may influence many physiological processes. As the phenotype resulting from complete ablation of the protein will represent the aggregate consequence of disrupting all physiological processes in which the protein is involved, effects on individual signaling pathways and processes may be obscured. In contrast, partial loss-of-function mutations may be able to separate these different roles. In addition, distinct proteins constituting parts of a complex of proteins may stabilize each other. Removal of one member of the complex may cause its partner proteins, which might exert distinct biochemical activities, to be degraded. Lastly, complete removal of a protein may allow a related family member to take the place of the deleted protein, thereby wholly or partially masking the function of the deleted protein.
Pitfalls associated with each of these cases can potentially be circumvented by the use of gene targeting to create point mutations in a gene ('knock-in' mutations), a more subtle approach that has become more common over the last decade. In this Perspective, we discuss each of the above hypothetical cases, using examples wherein these issues have been addressed using knock-in mutations of proteins involved in T cell antigen receptor (TCR) signaling.
Proteins with several biochemical functions
The Vav1 protein contains eight distinct domains (Fig. 1) . Its only known enzymatic activity is as a guanine nucleotide exchange factor (GEF) for Rho-family GTPases 13 . This activity resides in the Dbl homology (DH) domain. However, the presence of other domains, particularly SH2 and SH3 domains, led to the suggestion that it may also function as an adaptor protein 14 . Germline deletion of Vav1 indicated that Vav1 is important in signal transduction downstream of the TCR 13 . Several TCR-induced signaling events, including calcium influx and activation of Erk MAP kinase, protein kinase D, phosphatidylinositol-3-OH kinase (PI(3)K) and integrins, are impaired in the absence of Vav1. These defects lead to reduced T cell activation and cytokine synthesis.
From the knockout, it is not possible to tell whether the GEF activity of Vav1 is required for all, some or none of the observed consequences of Vav1 deletion. However, the issue was resolved by inserting a mutation into the DH domain of Vav1, which eliminates the GEF activity but does not affect DH domain folding or the integrity of any other domain (A. Saveliev, L. Vanes, J. Rapley, S. Smerdon, K. Rittinger et al., unpublished data). Analysis of this mutant shows that GEF activity is indeed important for Vav1 function but that Vav1 GEF activity is only required for transduction of TCR signals in a subset of Vav1-dependent pathways. The knock-in mutation revealed that in the absence of Vav1 GEF activity, TCR-induced PI(3)K activation is defective but calcium flux and Erk activation are normal. In addition, the GEF activity of Vav1 is largely dispensable for passage through the pre-TCR checkpoint of T cell development, which is blocked in Vav1-knockout mice. Thus, signals transmitted during distinct stages of T cell development differentially 'utilize' the GEF and non-GEF functions of Vav1, a conclusion that could not have been drawn using a conventional knockout.
The LAT transmembrane adaptor protein contains nine conserved tyrosine residues in its cytoplasmic domain ( Fig. 1) . TCR signaling results in rapid phosphorylation of these tyrosine residues, which in turn act as docking sites for the recruitment of other signaling proteins. Proteins that bind either directly or indirectly to these phosphorylated tyrosine residues include phospholipase C (PLC)-γ1; PI(3)K; Vav1; the adaptor proteins Grb2, Gads and SLP76; the tyrosine kinase Itk; and the Cbl E3 ubiquitin ligase. Individual tyrosine residues bind different proteins in vitro. For example, whereas phosphorylated Tyr136 binds PLC-γ1, phosphorylation of Tyr175 and Tyr195 generates binding sites for Grb2 and Gads, and phosphorylated Tyr235 can bind Grb2 (ref. 16 ). The importance of LAT in T cell signaling is illustrated by the phenotype of LAT knockout mice, which show a complete block in T cell development at the pre-TCR checkpoint 5 . Mice bearing knock-in point mutations in LAT have been generated and provide some insight into the roles of the different LAT tyrosine residues. Mutation of the three distal tyrosines (Tyr175, Tyr195 and Tyr235) or of these three residues as well as Tyr136 results in the same developmental block as seen in LAT knockout mice, showing the importance of these residues for LAT function 16, 17 . In contrast, mice bearing a mutation in only Tyr136 develop lymphadenopathy and splenomegaly and show signs of autoimmunity [18] [19] [20] . These mice accumulate T cells producing large amounts of interleukin-4, which leads to eosinophilia and an accumulation of plasma cells secreting immunoglobulin E (IgE). Biochemical analysis indicates that the Y136F mutation abrogates TCR-induced PLC-γ1 activation and calcium flux, in agreement with the observation that PLC-γ1 binds to phosphorylated Tyr136. The more severe T cell development phenotype seen in mice bearing mutations in the three distal tyrosine residues is likely to be due to the role of these residues in recruiting Gads and/or Grb2. Thus, different LAT tyrosine residues influence distinct biochemical pathways and thereby play different roles in positive and negative regulation of T cell activation. Tyr136, for example, seems to have a more prominent role in the negative regulation of T cell activation. A knock-in approach was needed to assign different functions to different parts of the protein.
The SLP76 cytoplasmic adaptor protein is able to bind to various other signaling proteins through several different domains, including a cluster of three tyrosine residues that become phosphorylated upon TCR activation (Tyr112, Tyr128 and Tyr145), a proline-rich (PR) domain and an SH2 domain (Fig. 1) . As with LAT, germline deletion of the gene encoding SLP76 results in a complete block in T cell 
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development at the pre-TCR checkpoint 3, 4 , and knock-in mutations revealed that the three tyrosine residues perform distinct functions. Whereas TCR-induced calcium flux, Erk activation and phosphorylation of PLC-γ1 require all three tyrosine residues, TCR-induced phosphorylation of Vav1 requires Tyr112 and Tyr128; and Tyr145 is more important for the activation of Itk (ref. 21) . Notably, compound mutant mice expressing the Y112F Y128F mutant SLP76 protein from one allele and the Y145F mutant from the other allele show near-normal T cell activation, suggesting the involvement of at least two SLP76 molecules in a multimeric signaling complex. In contrast, mutations in the PR region and the SH2 domain result in different phenotypes. Both mutations perturb T cell activation but to a lesser extent than mutations in the tyrosine residues 22 . Furthermore, the PR domain is required for a normal calcium flux, whereas the SH2 mutation does not affect this pathway. Once again, subtle mutations were needed for fine dissection of SLP76 function.
Partial loss-of-function mutations
The ZAP70 protein tyrosine kinase is important in transducing TCR signals. ZAP70 knockout mice show a complete block in thymocyte positive selection and contain no mature T cells 1, 2 . A spontaneously arising point mutation (R464C) in a conserved region of the kinase domain of ZAP70 ( Fig. 1) completely eliminates kinase activity and results in a phenotype identical to that of ZAP70 knockout mice, demonstrating that the kinase activity of ZAP70 is essential for normal positive selection of thymocytes 23 . However, a series of chemically induced point mutations in ZAP70 (I367F, W504R and the compound I367F W504R mutation) affect kinase activity to different degrees and result in a graded spectrum of phenotypes 24 . Different physiological processes show different sensitivity to reductions in ZAP70 kinase activity. Mild reductions in activity impair positive selection of CD4 + T cells, whereas a moderate reduction causes failures of thymic negative selection, memory antibody responses in the germinal center and development of regulatory T cells. Finally, an even stronger reduction in activity is required to eliminate T cell help for IgE and IgG autoantibody production, positive selection of CD8 + T cells and maintenance of CD4 + and CD8 + memory T cells. As a consequence, a moderate reduction in ZAP70 activity results in autoimmunity, a phenotype that is not seen in ZAP70 knockout mice. Notably, an autoimmune arthritis had been previously reported in mice bearing a spontaneous point mutation in ZAP70 (W163C) 25 . Together, these results illustrate that an allelic series of point mutants with partial loss of function can reveal roles for a protein in a range of physiological processes that could not be seen with a straightforward null mutant. Despite these insights, it remains unclear in the case of the ZAP70 mutants whether the observed phenotypes reflect roles for ZAP70 in TCR signaling in mature T cells or whether they are a consequence of altered thymic selection. A resolution of this issue will require conditional, stage-specific point mutations in which wild-type ZAP70 is expressed during thymic development but then expression switches to the mutant protein in mature T cells. The methodology required for these experiments has recently become available 26 .
Proteins in complexes
Class IA PI(3)K heterodimers consist of a catalytic subunit (p110α, p110β or p110δ) constitutively bound to an adaptor protein (p85α, p55α, p50α, p85β or p55γ) (Fig. 1) 27 . This association is important for protein stability, as shown in several knockout models. Whereas disruption of the Pik3r1 gene eliminates p85α, p55α and p50α proteins (pan-p85α knockout), it also causes an increase in the quantity of p85β and a decrease in the quantity of p110α, p110β and p110δ proteins 28, 29 .
Conversely, knockout of p110δ results in decreased quantities of p85α, p55α and p50α (ref. 30) . Thus, interpretation of the phenotypes of these mutants is complicated, as they could be due to absence of the targeted protein or to secondary changes in the quantities of associated proteins. To avoid these complications, another study knocked a point mutation (D910A) into p110δ that eliminates kinase activity but leaves the protein otherwise intact. In this case, the quantities of p85α, p55α, p50α, p110α, p110β and p110δ remained unchanged, and thus any observed phenotypic changes could be ascribed to loss of p110δ kinase activity 31 . Although the B cell phenotypes in the p110δ knockout and knock-in mutants seem to be similar, it is only because of the knock-in mutant that we can be sure that they are caused by a lack of p110δ kinase activity and not by effects on other proteins.
The class IB PI(3)K is a heterodimer consisting of a p110γ catalytic subunit and a p101 adaptor protein. Both a knockout and a knock-in mutant of p110γ have been generated. The latter mutation, K833R, eliminates kinase activity. Notably, whereas both mutants show a similar reduction in chemokine receptor function in hematopoietic cells, they show clear differences in signaling in cardiomyocytes [32] [33] [34] . In p110γ knockout cardiomyocytes, contractility is increased, but this effect is not seen in the knock-in mutant. This phenotypic difference revealed an unexpected, kinase-independent role of p110γ as an adaptor protein. In its capacity as an adaptor protein, p110γ binds to phosphodiesterase-3B (PDE3B), an enzyme necessary to degrade cyclic AMP, a second messenger that regulates cardiac contractility. Once again, the knock-in mutation was able to provide mechanistic insight that could not be obtained from the knockout.
Compensation by family members
The Cbl E3 ubiquitin ligase negatively regulates TCR signaling by causing ubiquitination and subsequent degradation of key signaling proteins 35 . Cbl contains several domains, including a tyrosine kinase binding (TKB) domain that binds to substrates, a RING finger domain that binds to an E2 ubiquitin ligase, and a proline-rich domain (Fig. 1) . Unlike the Cbl knockout, a point mutation (C379A) that inactivates the RING finger domain of Cbl results in embryonic lethality 36 . The most likely explanation for this discrepancy is that in the knockout, the related Cbl-b protein is able to take the place of Cbl, whereas in the C379A knock-in mutant, access is blocked by the mutant Cbl protein. This interpretation is supported by the Cbl Cbl-b double knockout, which also dies in utero. Thus, in this instance, a knock-in mutation was able to reveal a fuller picture of the physiological role of the protein than could be seen with a conventional knockout mutation. But it is clear from this example, and others, that in either case, the knockout and knock-in mutants provide complementary information, emphasizing the utility of studying both genetic alterations in parallel.
A knock-in mutation in the TKB domain of Cbl (G304E) illustrates another reason for using knock-in gene targeting strategies to study protein function. Studies in the Jurkat T cell line had shown that this mutation eliminates negative regulation of the ZAP70 kinase, leading to its hyperphosphorylation 35 . However, this phenotype was not observed in the knock-in mice, in which phosphorylation of ZAP70 was unaffected, as were downstream ZAP70-dependent pathways, such as TCR-induced activation of Erk and Akt. These findings underscore the dangers associated with extrapolation of conclusions from transformed cell lines to signaling processes in primary lymphocytes 37 .
Concluding remarks
The ability to use gene targeting to introduce essentially any mutation into the mouse genome has allowed the study of mutated signaling proteins in primary lymphocytes. Such knock-in mutations are shedding light on mechanistic aspects of signaling processes that could not have been deciphered using knockout mutations. Clearly, in the study of any new signaling protein, it will usually be advisable to make the null mutation by knocking out gene function fully. However, where insights into protein structure allow, these should be combined with point mutants to enable accurate analysis of protein function in distinct signaling pathways.
In this regard, knowledge of protein structure is a prerequisite for the rational design of such mutations. To understand the role of any given domain, it is important to mutate one or more residues critical for function but not for domain folding. Unfolded domains could destabilize the rest of the protein, leading to its degradation; could interfere with the function of other domains; or, by exposure of hydrophobic surfaces, could lead to protein insolubility. All of the above phenomena would simply result in replication of the knockout phenotype. Similarly, domain deletions can affect the remainder of the protein, as domains often interact with each other in a native structure, and removal of one domain can affect the folding, solubility or function of another. In the case of some domains, such as kinase or SH2 domains, many atomic resolution-structures are available, and so it is fairly straightforward to design mutations that eliminate function of the domain without unfolding it. However, in other cases, an absence of structural insight may make it difficult to identify suitable residues to mutate. In such cases, it is advisable to first carefully examine the effects of planned point mutations in vitro, looking at domain function and stability, before committing effort to the generation of a knock-in mouse mutant.
The analysis of signal transduction in lymphocytes has changed over the past 25 years, driven primarily by the availability of genomic sequences and by technical improvements in genetic manipulation. Access to genomic sequences has made possible whole-genome analysis, thereby allowing simultaneous analysis of multiple signaling pathways. The genetic analysis of signaling has become easier with the advent of gene targeting, allowing the generation of constitutive knockouts, conditional knockouts and point mutations of any gene in the mouse genome. Most recently, a combination of these approaches has allowed the generation of conditional knock-in mutations 26 . Thus, it is now possible to generate specific point mutations in a tissue-specific or inducible manner, allowing an unprecedented level of genetic control during the analysis of signaling pathways.
